Docetaxel Combined With Carboplatin Plus Anlotinib as First Line Treatment in NSCLC
Clinical trial NCT03799601 · UNKNOWN
Trial details
- NCT number
- NCT03799601
- Sponsor
- Tongji Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-01
- Primary completion
- 2019-12-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.